Susquehanna International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.88M | Sell |
77,262
-5,718
| -7% | -$361K | ﹤0.01% | 1325 |
|
2025
Q1 | $4.4M | Buy |
82,980
+32,316
| +64% | +$1.71M | ﹤0.01% | 1347 |
|
2024
Q4 | $2.84M | Buy |
50,664
+29,183
| +136% | +$1.63M | ﹤0.01% | 1580 |
|
2024
Q3 | $1.13M | Sell |
21,481
-2,644
| -11% | -$139K | ﹤0.01% | 2522 |
|
2024
Q2 | $991K | Sell |
24,125
-79,128
| -77% | -$3.25M | ﹤0.01% | 2591 |
|
2024
Q1 | $4.47M | Buy |
103,253
+71,021
| +220% | +$3.08M | ﹤0.01% | 1099 |
|
2023
Q4 | $1.48M | Buy |
32,232
+1,776
| +6% | +$81.6K | ﹤0.01% | 2313 |
|
2023
Q3 | $698K | Buy |
30,456
+14,158
| +87% | +$325K | ﹤0.01% | 2985 |
|
2023
Q2 | $269K | Sell |
16,298
-768,257
| -98% | -$12.7M | ﹤0.01% | 4344 |
|
2023
Q1 | $14M | Buy |
784,555
+90,513
| +13% | +$1.61M | ﹤0.01% | 591 |
|
2022
Q4 | $20.2M | Buy |
694,042
+479,520
| +224% | +$14M | 0.01% | 344 |
|
2022
Q3 | $5.26M | Buy |
214,522
+150,261
| +234% | +$3.68M | ﹤0.01% | 816 |
|
2022
Q2 | $267K | Buy |
64,261
+46,590
| +264% | +$194K | ﹤0.01% | 4148 |
|
2022
Q1 | $204K | Sell |
17,671
-46,797
| -73% | -$540K | ﹤0.01% | 4799 |
|
2021
Q4 | $643K | Buy |
64,468
+11,265
| +21% | +$112K | ﹤0.01% | 3445 |
|
2021
Q3 | $695K | Buy |
53,203
+9,668
| +22% | +$126K | ﹤0.01% | 3261 |
|
2021
Q2 | $852K | Sell |
43,535
-80,202
| -65% | -$1.57M | ﹤0.01% | 3191 |
|
2021
Q1 | $2.63M | Buy |
123,737
+72,222
| +140% | +$1.54M | ﹤0.01% | 1812 |
|
2020
Q4 | $1.53M | Sell |
51,515
-17,751
| -26% | -$528K | ﹤0.01% | 2031 |
|
2020
Q3 | $1.5M | Buy |
69,266
+59,391
| +601% | +$1.29M | ﹤0.01% | 1719 |
|
2020
Q2 | $220K | Sell |
9,875
-5,830
| -37% | -$130K | ﹤0.01% | 3631 |
|
2020
Q1 | $239K | Buy |
+15,705
| New | +$239K | ﹤0.01% | 3642 |
|
2019
Q4 | – | Sell |
-11,782
| Closed | -$254K | – | 4683 |
|
2019
Q3 | $254K | Sell |
11,782
-3,148
| -21% | -$67.9K | ﹤0.01% | 3614 |
|
2019
Q2 | $328K | Buy |
+14,930
| New | +$328K | ﹤0.01% | 3372 |
|